Kyung Seob Lim

Title: Innovations of Kyung Seob Lim in Drug-Eluting Stents

Introduction

Kyung Seob Lim is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of medical devices, particularly in the development of drug-eluting stents. With a total of seven patents to his name, Lim's work focuses on enhancing the efficacy and safety of stents used in coronary interventions.

Latest Patents

One of Lim's latest patents is a non-polymeric tacrolimus drug-eluting stent and the manufacturing method associated with it. This innovative method allows for a strong and stable binding of tacrolimus drug onto the stent without the need for a separate step to introduce surface-binding functional groups. The resulting stent exhibits a greater total drug elution amount and improved delayed drug-elution properties. Another notable patent is for a method of manufacturing a polymer-free everolimus-eluting coronary stent fabricated using an electrospinning technique. This method enables precise control over the total content of the everolimus-based drug while forming a uniform layer, eliminating the use of polymers that can lead to late thrombosis.

Career Highlights

Kyung Seob Lim has worked with esteemed institutions such as Chonnam National University and Jeonnam Technopark. His experience in these organizations has allowed him to collaborate on various research projects aimed at advancing medical technology.

Collaborations

Lim has collaborated with notable colleagues, including Dae Sung Park and So Youn Lee. Their combined expertise has contributed to the successful development of innovative medical devices.

Conclusion

Kyung Seob Lim's contributions to the field of drug-eluting stents demonstrate his commitment to improving patient outcomes through innovation. His patents reflect a deep understanding of medical technology and a dedication to advancing healthcare solutions.